ProfileGDS4095 / 231171_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 62% 60% 55% 53% 55% 60% 63% 63% 65% 64% 64% 63% 65% 63% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep15.1731862
GSM709769LY2 SRC1-siRNA tamoxifen treated rep34.7398760
GSM709765LY2 SRC1-siRNA untreated rep34.0939355
GSM709771LY2 SRC1-siRNA untreated rep13.815753
GSM709772LY2 SRC1-siRNA untreated rep24.102655
GSM709775LY2 SRC1-siRNA untreated rep44.7022460
GSM709764LY2 control-siRNA tamoxifen treated rep25.2573563
GSM709766LY2 control-siRNA tamoxifen treated rep35.3051863
GSM709768LY2 control-siRNA tamoxifen treated rep15.6539865
GSM709777LY2 control-siRNA tamoxifen treated rep45.4272664
GSM709770LY2 control-siRNA untreated rep35.6004364
GSM709773LY2 control-siRNA untreated rep15.3380463
GSM709774LY2 control-siRNA untreated rep25.6299565
GSM709776LY2 control-siRNA untreated rep45.2970163